Cite
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
MLA
La Nasa, Giorgio, et al. “The Favorable Role of Homozygosity for Killer Immunoglobulin-like Receptor (KIR) A Haplotype in Patients with Advanced-Stage Classic Hodgkin Lymphoma.” Journal of Hematology & Oncology, vol. 9, Mar. 2016, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13045-016-0255-4.
APA
La Nasa, G., Greco, M., Littera, R., Oppi, S., Celeghini, I., Caria, R., Lai, S., Porcella, R., Martino, M., Romano, A., Di Raimondo, F., Gallamini, A., Carcassi, C., & Caocci, G. (2016). The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma. Journal of Hematology & Oncology, 9, 1–9. https://doi.org/10.1186/s13045-016-0255-4
Chicago
La Nasa, Giorgio, Marianna Greco, Roberto Littera, Sara Oppi, Ivana Celeghini, Rossella Caria, Sara Lai, et al. 2016. “The Favorable Role of Homozygosity for Killer Immunoglobulin-like Receptor (KIR) A Haplotype in Patients with Advanced-Stage Classic Hodgkin Lymphoma.” Journal of Hematology & Oncology 9 (March): 1–9. doi:10.1186/s13045-016-0255-4.